Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes

ABSTRACT Objective: There is controversy about the indication for nonalcoholic fatty liver disease (NAFLD) screening in patients with type 2 diabetes mellitus (T2D). The present study aims to contribute to NAFLD surveillance in patients with T2D, assessing the association of clinical and biological variables with hepatic stiffness and steatosis. Subjects and methods: A cross-sectional design was used, with data collection from electronic medical records, including adults with T2D who underwent transient elastography (TE) between June 2018 and December 2019. Liver stiffness and steatosis were evaluated using TE and controlled attenuation parameter (CAP), respectively, with cutoff points > 8 kpa for increased stiffness and > 275 dBm for steatosis. The relationship between clinical variables and elastography results were evaluated by bivariate correlation and multivariate analysis, using SPSS 27. Seventy-nine patients (n = 79) met the inclusion and exclusion criteria. Results: Advanced fibrosis and hepatic steatosis were detected in 17,7% and in 21,5% of the patients, respectively. There was a direct and significant correlation between CAP and BMI, waist circumference, HbA1c, triglycerides levels, and insulin doses and an inverse correlation with HDL. The waist circumference, low levels of HDL cholesterol and the insulin dose maintained a significant association with CAP values in multivariate analysis. Elastography values showed an inverse correlation with HDL and a direct correlation with BMI and insulin dose. The association was only maintained for the insulin dose in multivariate analysis. Conclusion: Our results suggest that clinical factors such as insulin dose, waist circumference, and HDL cholesterol levels could identify T2D patients more likely to present NAFLD.

Saved in:
Bibliographic Details
Main Authors: Pozzan,Roselee, Pena,Ronaldo Gama, Palma,Cátia Cristina Silva Sousa Vergara, Abi-Abib,Raquel de Carvalho, Terra,Carlos, Cobas,Roberta Arnoldi
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Endocrinologia e Metabologia 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000400452
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2359-39972022000400452
record_format ojs
spelling oai:scielo:S2359-399720220004004522022-09-27Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetesPozzan,RoseleePena,Ronaldo GamaPalma,Cátia Cristina Silva Sousa VergaraAbi-Abib,Raquel de CarvalhoTerra,CarlosCobas,Roberta Arnoldi Type 2 diabetes mellitus nonalcoholic fatty liver disease controlled attenuation parameter (CAP) elastography ABSTRACT Objective: There is controversy about the indication for nonalcoholic fatty liver disease (NAFLD) screening in patients with type 2 diabetes mellitus (T2D). The present study aims to contribute to NAFLD surveillance in patients with T2D, assessing the association of clinical and biological variables with hepatic stiffness and steatosis. Subjects and methods: A cross-sectional design was used, with data collection from electronic medical records, including adults with T2D who underwent transient elastography (TE) between June 2018 and December 2019. Liver stiffness and steatosis were evaluated using TE and controlled attenuation parameter (CAP), respectively, with cutoff points > 8 kpa for increased stiffness and > 275 dBm for steatosis. The relationship between clinical variables and elastography results were evaluated by bivariate correlation and multivariate analysis, using SPSS 27. Seventy-nine patients (n = 79) met the inclusion and exclusion criteria. Results: Advanced fibrosis and hepatic steatosis were detected in 17,7% and in 21,5% of the patients, respectively. There was a direct and significant correlation between CAP and BMI, waist circumference, HbA1c, triglycerides levels, and insulin doses and an inverse correlation with HDL. The waist circumference, low levels of HDL cholesterol and the insulin dose maintained a significant association with CAP values in multivariate analysis. Elastography values showed an inverse correlation with HDL and a direct correlation with BMI and insulin dose. The association was only maintained for the insulin dose in multivariate analysis. Conclusion: Our results suggest that clinical factors such as insulin dose, waist circumference, and HDL cholesterol levels could identify T2D patients more likely to present NAFLD.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArchives of Endocrinology and Metabolism v.66 n.4 20222022-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000400452en10.20945/2359-3997000000492
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Pozzan,Roselee
Pena,Ronaldo Gama
Palma,Cátia Cristina Silva Sousa Vergara
Abi-Abib,Raquel de Carvalho
Terra,Carlos
Cobas,Roberta Arnoldi
spellingShingle Pozzan,Roselee
Pena,Ronaldo Gama
Palma,Cátia Cristina Silva Sousa Vergara
Abi-Abib,Raquel de Carvalho
Terra,Carlos
Cobas,Roberta Arnoldi
Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes
author_facet Pozzan,Roselee
Pena,Ronaldo Gama
Palma,Cátia Cristina Silva Sousa Vergara
Abi-Abib,Raquel de Carvalho
Terra,Carlos
Cobas,Roberta Arnoldi
author_sort Pozzan,Roselee
title Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes
title_short Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes
title_full Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes
title_fullStr Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes
title_full_unstemmed Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes
title_sort risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes
description ABSTRACT Objective: There is controversy about the indication for nonalcoholic fatty liver disease (NAFLD) screening in patients with type 2 diabetes mellitus (T2D). The present study aims to contribute to NAFLD surveillance in patients with T2D, assessing the association of clinical and biological variables with hepatic stiffness and steatosis. Subjects and methods: A cross-sectional design was used, with data collection from electronic medical records, including adults with T2D who underwent transient elastography (TE) between June 2018 and December 2019. Liver stiffness and steatosis were evaluated using TE and controlled attenuation parameter (CAP), respectively, with cutoff points > 8 kpa for increased stiffness and > 275 dBm for steatosis. The relationship between clinical variables and elastography results were evaluated by bivariate correlation and multivariate analysis, using SPSS 27. Seventy-nine patients (n = 79) met the inclusion and exclusion criteria. Results: Advanced fibrosis and hepatic steatosis were detected in 17,7% and in 21,5% of the patients, respectively. There was a direct and significant correlation between CAP and BMI, waist circumference, HbA1c, triglycerides levels, and insulin doses and an inverse correlation with HDL. The waist circumference, low levels of HDL cholesterol and the insulin dose maintained a significant association with CAP values in multivariate analysis. Elastography values showed an inverse correlation with HDL and a direct correlation with BMI and insulin dose. The association was only maintained for the insulin dose in multivariate analysis. Conclusion: Our results suggest that clinical factors such as insulin dose, waist circumference, and HDL cholesterol levels could identify T2D patients more likely to present NAFLD.
publisher Sociedade Brasileira de Endocrinologia e Metabologia
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000400452
work_keys_str_mv AT pozzanroselee riskfactorsassociatedwithnonalcoholicfattyliverdiseaseevaluatedbyelastographyinpatientswithtype2diabetes
AT penaronaldogama riskfactorsassociatedwithnonalcoholicfattyliverdiseaseevaluatedbyelastographyinpatientswithtype2diabetes
AT palmacatiacristinasilvasousavergara riskfactorsassociatedwithnonalcoholicfattyliverdiseaseevaluatedbyelastographyinpatientswithtype2diabetes
AT abiabibraqueldecarvalho riskfactorsassociatedwithnonalcoholicfattyliverdiseaseevaluatedbyelastographyinpatientswithtype2diabetes
AT terracarlos riskfactorsassociatedwithnonalcoholicfattyliverdiseaseevaluatedbyelastographyinpatientswithtype2diabetes
AT cobasrobertaarnoldi riskfactorsassociatedwithnonalcoholicfattyliverdiseaseevaluatedbyelastographyinpatientswithtype2diabetes
_version_ 1756441500976152576